Pharmacological Inhibition of Amyloidogenic APP Processing and Knock-Down of APP in Primary Human Macrophages Impairs the Secretion of Cytokines
It has been previously shown that the amyloid precursor protein (APP) support the innate immune defense as an immune receptor. Amyloid β (Aβ) peptides seem to have properties of an antimicrobial peptide and can act as opsonines. In APP-deficient mouse models, a reduced secretion of cytokines has bee...
Main Authors: | Philipp Spitzer, Matthias Walter, Caroline Göth, Timo Jan Oberstein, Philipp Linning, Hans-Joachim Knölker, Johannes Kornhuber, Juan Manuel Maler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01967/full |
Similar Items
-
Expression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
by: Johannes Steffen, et al.
Published: (2017-06-01) -
Abstract P-34: The Regulation of Amyloid Proteins Aggregation by Adjacent Domains
by: Anastasia V. Grizel, et al.
Published: (2019-06-01) -
Contribution of GABAergic interneurons to amyloid-β plaque pathology in an APP knock-in mouse model
by: Heather C. Rice, et al.
Published: (2020-01-01) -
Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach
by: Florence Haut, et al.
Published: (2023-12-01) -
SNX8 Enhances Non-amyloidogenic APP Trafficking and Attenuates Aβ Accumulation and Memory Deficits in an AD Mouse
by: Yongzhuang Xie, et al.
Published: (2019-09-01)